Published in Menopause on September 01, 2015
Compounded non-FDA-approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey. Menopause (2016) 1.43
Management of Menopausal Symptoms. Obstet Gynecol (2015) 0.85
Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy. Menopause (2016) 0.77
Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study. PLoS One (2016) 0.75
Update on primary ovarian insufficiency. Curr Opin Endocrinol Diabetes Obes (2015) 0.75
Prescribing of FDA-approved and compounded hormone therapy differs by specialty. Menopause (2016) 0.75
Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries. Post Reprod Health (2016) 0.75
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene. Ther Clin Risk Manag (2016) 0.75
Compounded bioidentical hormone therapy: time for a reality check? Menopause (2015) 0.75
Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making. BMC Womens Health (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health (2006) 4.51
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Bioidentical hormone therapy: a review. Menopause (2004) 2.97
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative. Menopause (2012) 2.12
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause (2014) 1.75
Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause (2013) 1.68
Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat (2001) 1.68
A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol (2012) 1.67
Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause (2005) 1.30
Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 1.25
The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand (2004) 1.19
The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy. Menopause Int (2013) 1.17
Bioidentical hormone therapy: a review of the evidence. J Womens Health (Larchmt) (2007) 1.04
Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study . Menopause (2008) 1.01
Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010. Obstet Gynecol (2014) 0.99
Continuing decline in hormone therapy use: population trends over 17 years. Climacteric (2009) 0.98
Bioidentical hormone therapy: a panacea that lacks supportive evidence. Curr Opin Obstet Gynecol (2008) 0.97
Use of bioidentical compounded hormones for menopausal concerns: cross-sectional survey in an academic menopause center. J Womens Health (Larchmt) (2011) 0.96
Pharmacy compounding primer for physicians: prescriber beware. Drugs (2012) 0.94
Committee opinion No. 532: compounded bioidentical menopausal hormone therapy. Obstet Gynecol (2012) 0.93
Women's beliefs about "natural" hormones and natural hormone replacement therapy. Menopause (2001) 0.92
Breast cancer and menopause: perceptions of diagnosis, menopausal therapies and health behaviors. Climacteric (2011) 0.91
Short-term use of unopposed estrogen: a balance of inferred risks and benefits. JAMA (2011) 0.87
Compounded progesterone: why is it acceptable to Australian women? Maturitas (2012) 0.85
Compounded estradiol cream: a cost conscious alternative. J Okla State Med Assoc (2014) 0.84
Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy (2014) 0.84
Symptoms, health behavior and understanding of menopause therapy in women with premature menopause. Climacteric (2014) 0.81
Beliefs about bioidentical hormone therapy: a cross-sectional survey of pharmacists. Maturitas (2012) 0.80
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med (2014) 3.57
HIV infection and bone mineral density in middle-aged women. Clin Infect Dis (2006) 2.67
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48
Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab (2003) 2.47
Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod (2009) 2.26
Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation. Am J Obstet Gynecol (2008) 2.15
Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med (2015) 1.65
Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause (2012) 1.65
Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation. Menopause (2009) 1.64
Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril (2008) 1.64
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol (2012) 1.62
Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol (1985) (2005) 1.60
Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition. Menopause (2011) 1.56
Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause (2008) 1.54
Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues (2005) 1.52
Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab (2007) 1.50
Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls. J Adolesc Health (2008) 1.47
The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab (2002) 1.47
Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care (2004) 1.45
Assessing comprehension of clinical research. Contemp Clin Trials (2011) 1.44
Consistent ovulation may not be enough to make women healthy when approaching menopause: an update from the Study of Women's Health Across the Nation. Menopause (2015) 1.39
Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30
Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab (2010) 1.29
Menopause symptoms in HIV-infected and drug-using women. Menopause (2005) 1.27
HIV infection, drug use, and onset of natural menopause. Clin Infect Dis (2005) 1.24
Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab (2012) 1.24
Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab (2009) 1.22
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause (2006) 1.18
Cardiovascular risk factor variation within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation. Ethn Dis (2010) 1.16
The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials (2012) 1.15
Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health (Lond Engl) (2009) 1.14
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab (2006) 1.14
Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod (2010) 1.13
Overweight men: clinical pregnancy after ART is decreased in IVF but not in ICSI cycles. J Assist Reprod Genet (2010) 1.12
Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med (2005) 1.08
Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol (2010) 1.08
Age-related decline in fertility. Endocrinol Metab Clin North Am (2003) 1.08
Recruitment challenges of a multicenter randomized controlled varicocelectomy trial. Fertil Steril (2011) 1.05
Endometrial thickness, Caucasian ethnicity, and age predict clinical pregnancy following fresh blastocyst embryo transfer: a retrospective cohort. Reprod Biol Endocrinol (2009) 1.04
Risk factor clustering in the insulin resistance syndrome and its relationship to cardiovascular disease in postmenopausal white, black, hispanic, and Asian/Pacific Islander women. Metabolism (2003) 1.03
Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2014) 1.02
Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02
Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril (2008) 1.02
Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis (2011) 0.99
Longitudinal changes in hypothalamic and ovarian function in perimenopausal women with anovulatory cycles: relationship with vasomotor symptoms. Fertil Steril (2008) 0.99
Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab (2011) 0.98
The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet Gynecol (2008) 0.97
Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev (2002) 0.95
The nucleolar channel system of human endometrium is related to endoplasmic reticulum and R-rings. Mol Biol Cell (2007) 0.95
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
The menopausal transition: characteristics and management. Best Pract Res Clin Endocrinol Metab (2003) 0.92
Postthaw blastomere survival is predictive of the success of frozen-thawed embryo transfer cycles. Fertil Steril (2004) 0.89
The reproductive endocrinology of the menopausal transition. Steroids (2011) 0.89
Association of adolescent obesity and lifetime nulliparity--the Study of Women's Health Across the Nation (SWAN). Fertil Steril (2009) 0.89
Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women. Menopause (2008) 0.88
Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab (2014) 0.87
Onset of ovulation after menarche in girls: a longitudinal study. J Clin Endocrinol Metab (2008) 0.86
Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J Clin Endocrinol Metab (2012) 0.86
Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort. Am J Epidemiol (2008) 0.86
Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium. Hum Reprod (2009) 0.86
Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study. Cardiovasc Diabetol (2012) 0.86
Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR. Fertil Steril (2007) 0.86
Nuclear pore complex proteins mark the implantation window in human endometrium. J Cell Sci (2008) 0.86
Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril (2008) 0.86
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. Maturitas (2011) 0.85
Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance. Am J Physiol Endocrinol Metab (2011) 0.85
Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women. Obesity (Silver Spring) (2013) 0.84
Assessment of luteal function in the vervet monkey as a means to develop a model for obesity-related reproductive phenotype. Syst Biol Reprod Med (2013) 0.84
Differential granulosa cell gene expression in young women with diminished ovarian reserve. Reprod Sci (2011) 0.84
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 0.83
Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83
Reproductive aging and its consequences for general health. Ann N Y Acad Sci (2010) 0.82
Inhibins, activins, and follistatin in the aging female and male. Semin Reprod Med (2004) 0.82
Sibling and self ovum donation for sisters with an intermediate FMR1 mutation: what's a program to do? Fertil Steril (2009) 0.82
HIV and the menopause. Menopause Int (2008) 0.82
Luteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight women. Clin Endocrinol (Oxf) (2014) 0.81
Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery. Reprod Sci (2010) 0.81
Comparison of SWAN and WISE menopausal status classification algorithms. J Womens Health (Larchmt) (2006) 0.81
Reproductive aging is associated with altered gene expression in human luteinized granulosa cells. Reprod Sci (2009) 0.81
The nucleolar channel system reliably marks the midluteal endometrium regardless of fertility status: a fresh look at an old organelle. Fertil Steril (2010) 0.81
Proactively establishing a biologic specimens repository for large clinical trials: an idea whose time has come. Syst Biol Reprod Med (2011) 0.81
The Stages of Reproductive Aging Workshop. Menopause (2002) 0.80
Lessons learned from the WHI: HRT requires a cautious and individualized approach. Geriatrics (2004) 0.80
Serum progesterone on the day of human chorionic gonadotropin administration predicts clinical pregnancy of sibling frozen embryos. Fertil Steril (2008) 0.80
Endogenous estradiol is associated with verbal memory in nondemented older men. Brain Cogn (2011) 0.80
In vitro evidence of glucose-induced toxicity in GnRH secreting neurons: high glucose concentrations influence GnRH secretion, impair cell viability, and induce apoptosis in the GT1-1 neuronal cell line. Fertil Steril (2007) 0.79
Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study. Obesity (Silver Spring) (2013) 0.79
Predictors of pregnancy and live birth after insemination in couples with unexplained or male-factor infertility. Fertil Steril (2012) 0.79
Aromatase inhibition causes increased amplitude, but not frequency, of hypothalamic-pituitary output in normal women. Fertil Steril (2011) 0.78
Reduced neurotrophin receptor tropomyosin-related kinase A expression in human granulosa cells: a novel marker of diminishing ovarian reserve. Fertil Steril (2011) 0.78
Impaired gremlin 1 (GREM1) expression in cumulus cells in young women with diminished ovarian reserve (DOR). J Assist Reprod Genet (2011) 0.78
Establishing a biologic specimens repository for reproductive clinical trials: technical aspects. Syst Biol Reprod Med (2011) 0.78
Endocrine mechanisms and management for abnormal bleeding due to perimenopausal changes. Clin Obstet Gynecol (2005) 0.78
Increasing burden of institutional review in multicenter clinical trials of infertility: the Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies. Fertil Steril (2011) 0.77
Evidence of GnRH antagonist escape in obese women. J Clin Endocrinol Metab (2014) 0.77
Skin wrinkles and rigidity in early postmenopausal women vary by race/ethnicity: baseline characteristics of the skin ancillary study of the KEEPS trial. Fertil Steril (2010) 0.77
Heterogeneity in endometrial expression of aromatase in polyp-bearing uteri. Hum Reprod (2007) 0.77
Mechanism of formation of the major estradiol product ions following collisional activation of the molecular anion in a tandem quadrupole mass spectrometer. J Am Soc Mass Spectrom (2013) 0.77